FOXM1 and cancer: Among the 150 genes upregulated in refractory AML blast cells (Table S4), the most significant enrichment among the 92 sets of transcription factor binding sites interrogated was for genes bound by the Forkhead transcription factor FOXM1 (Fig. 3D), whose expression is known to predict for adverse outcomes in cancer [7, 8].